Navana Pharmaceuticals PLC (DSE: NAVANAPHAR)
Bangladesh
· Delayed Price · Currency is BDT
66.70
+0.40 (0.60%)
At close: Sep 12, 2024
Navana Pharmaceuticals Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 11, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| Market Capitalization | 7,165 | 12,546 | - | - | - |
| Enterprise Value | 11,632 | 15,739 | - | - | - |
| Last Close Price | 66.70 | 114.98 | - | - | - |
| PE Ratio | 16.30 | 32.02 | - | - | - |
| PS Ratio | 1.10 | 2.20 | - | - | - |
| PB Ratio | 1.58 | 2.87 | - | - | - |
| P/FCF Ratio | -11.31 | -8.93 | - | - | - |
| P/OCF Ratio | 106.70 | 64.76 | - | - | - |
| EV/Sales Ratio | 1.79 | 2.76 | - | - | - |
| EV/EBITDA Ratio | 10.81 | 17.84 | - | - | - |
| EV/EBIT Ratio | 13.44 | 21.81 | - | - | - |
| EV/FCF Ratio | -13.87 | -11.21 | - | - | - |
| Debt / Equity Ratio | 1.09 | 0.99 | 0.86 | 0.45 | 0.31 |
| Debt / EBITDA Ratio | 4.56 | 4.65 | 4.09 | 3.42 | 2.82 |
| Debt / FCF Ratio | -5.85 | -3.08 | -2.60 | -3.74 | 5.32 |
| Asset Turnover | 0.68 | 0.68 | 0.77 | 0.75 | - |
| Inventory Turnover | 1.48 | 2.28 | 2.47 | 2.27 | - |
| Quick Ratio | 0.23 | 0.26 | 0.19 | 0.31 | 0.39 |
| Current Ratio | 0.95 | 0.99 | 0.88 | 1.15 | 1.31 |
| Return on Equity (ROE) | 9.87% | 9.09% | 8.07% | 6.32% | - |
| Return on Assets (ROA) | 5.62% | 5.41% | 5.80% | 4.52% | - |
| Return on Capital (ROIC) | 6.12% | 5.93% | 6.31% | 4.92% | - |
| Earnings Yield | 6.13% | 2.85% | - | - | - |
| FCF Yield | -11.70% | -11.19% | - | - | - |
| Dividend Yield | 1.95% | 1.13% | - | - | - |
| Payout Ratio | 30.22% | 31.70% | - | - | - |
| Buyback Yield / Dilution | -16.28% | -23.91% | - | - | - |
| Total Shareholder Return | -14.33% | -22.78% | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.